Compounds > cilomilast
Page last updated: 2024-09-04

cilomilast and enoxacin

cilomilast has been researched along with enoxacin in 2 studies

Compound Research Comparison

Studies
(cilomilast)		Trials
(cilomilast)		Recent Studies (post-2010)
(cilomilast)		Studies
(enoxacin)		Trials
(enoxacin)		Recent Studies (post-2010) (enoxacin)
162134273474122

Protein Interaction Comparison

ProteinTaxonomycilomilast (IC50)enoxacin (IC50)
V-type proton ATPase subunit B, brain isoformHomo sapiens (human)10
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)10
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)10
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)10
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)10
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)10
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)10
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)10

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Balliano, TL; Barbosa, G; Carvalho, VF; da Silva, BA; de Souza, ET; Lima, LM; Martins, IRR; Martins, MA; Medeiros, MM; Moraes Junior, MO; Nunes, IKDC; Silva, PMR; Silva, SWD1

Other Studies

2 other study(ies) available for cilomilast and enoxacin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies.
    European journal of medicinal chemistry, 2020, Oct-15, Volume: 204

    Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Design; Enzyme Inhibitors; Humans; Hydrazones; Hypersensitivity; Lung; Male; Mice

2020